Exploring how gut microbiome changes during psoriasis treatment with Secukinumab and Ustekinumab affect therapeutic outcomes through the gut-skin axis.
Exploring how microbial imbalances in the skin microbiome contribute to psoriasis development and potential microbiome-targeted treatments.